Palisade Bio
PublicPalisade Bio is now publicly traded
The data on this page reflects Palisade Bio's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Oct 2, 2025
Total Funding Raised
$196.18M
Company Overview
Palisade Bio (NAS: PALI) is a biopharmaceutical company dedicated to discovering and developing therapies aimed at preserving the integrity of the intestinal barrier.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Palisade Bio Comparables
Compare Palisade Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Union Therapeutics | 70% | |
| Artus Therapeutics | 33% |
Palisade Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Oct 2, 2025 | ||||
| Follow-on Offering | Jul 23, 2025 | ||||
| Grant | Feb 20, 2025 | ||||
| Follow-on Offering | Dec 13, 2024 | ||||
| Private Placement | May 7, 2024 | ||||
Private Placement | Sep 11, 2023 |
Palisade Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Follow-on Offering |
| ADAR1 Capital Management | Follow-on Offering |
| RA Capital Management | Follow-on Offering |
| Boxer Capital | Follow-on Offering |
| Perceptive Advisors | Follow-on Offering |
| B Capital Group | Follow-on Offering |
| Columbia Threadneedle Investments | Follow-on Offering |
Palisade Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access